23andMe Holding Co.
NASDAQ:ME
23andMe Holding Co.
NASDAQ:ME
Price:
0.5023 USD
-0.46%
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
The Relative Value of one
ME
stock under the Base Case scenario is
2.4234
USD.
Compared to the current market price of 0.5023 USD,
23andMe Holding Co.
is
Undervalued by 79%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ME
Relative Value
Base Case
2.4234
USD
Undervaluation 79%
Valuation Multiples
Multiples Across Competitors
ME Competitors Multiples
23andMe Holding Co. Competitors
23andMe Holding Co. Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
23andMe Holding Co.
NASDAQ:ME
|
240.5m USD | 1 | -0.5 | 0.1 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
94.9B EUR | 0.5 | 19.8 | 10.2 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
99.9B USD | 0.5 | 19.3 | 10 | 13.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70B USD | 0.2 | 9.6 | 8.7 | 8.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 1.6 | 18.1 | 10.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 0.6 | 23.9 | 7 | 16.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 0.6 | 23.1 | 6.9 | 16.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
11.9B USD | 1 | 17.3 | 8.4 | 12.4 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
